Key Development The Vietnamese pharmaceutical market recently witnessed a significant infrastructure realignment as the Ministry of Health approved the voluntary... Read more
Category: Uncategorized
The European Commission approves Gilead’s Trodelvy as a first-line treatment for metastatic triple-negative breast cancer
Biopharmaceutical pioneer Gilead Sciences, Inc. announced that the European Commission (EC) has formally granted marketing authorization for its flagship oncology... Read more
Merck collaborates with Versant Ventures to launch Saturnus Bio to advance precision therapies for rare genetic cardiomyopathies
Global science and technology leader Merck has finalized a strategic research-stage collaboration with premier venture capital firm Versant Ventures to... Read more
The nearly VND 5 trillion Bach Mai Hospital branch in Ninh Binh to launch operations on June 26
On June 26, 2026, the Ninh Binh branch of Bach Mai Hospital—a landmark national healthcare project drawing an aggregate investment... Read more
The Drug Administration of Vietnam proposes revoking 286 cosmetic registration numbers including LEMONADE, Focallure, Johnson’s, and Neutrogena
The Drug Administration of Vietnam (DAV), under the Ministry of Health, has officially drafted an administrative decree to revoke 286... Read more
Missouri appeals court rejects Abbott’s transfer petition, leaving the $495 million preterm infant formula verdict standing
A Missouri appeals court has formally declined to transfer Abbott Laboratories’ appeal of a landmark $495 million product liability verdict... Read more
Eli Lilly projects Trump’s MFN pricing frameworks will disrupt European obesity drug launch configurations
Multinational pharmaceutical leader Eli Lilly and Co. announced that it anticipates launching its highly anticipated oral weight-loss pill within Europe... Read more
BioPharma Dive Report: Pfizer’s Seagen-acquired ADC fails pivotal late-stage lung cancer study
A closely watched experimental oncology drug positioned by Pfizer Inc. as a cornerstone of its future revenue portfolio has failed... Read more
Carl Zeiss hosts seminar series: Advancing myopia progression management via a high-tech ophthalmic ecosystem
German optical technology leader Carl Zeiss has officially launched a specialized symposium series titled "The Future of Myopia Progression Management... Read more








